Similar companies
Did Tempest Therapeutics Beat Earnings?
Tempest Therapeutics (TPST) reported Q4 '25 revenue of $0, down 100.0% year-over-year.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Tempest Therapeutics’s job postings, web traffic, and employee business outlook. See the full TPST stock analysis or the earnings calendar for upcoming reports.
Tempest Therapeutics Quarterly Financial Trends
| Metric | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 490,000 | 490,000 | — | — | — |
| Gross margin | — | — | — | 50.0% | -14.0% | — | — | — |
| Operating margin | — | — | — | -2,863.8% | -2,250.2% | — | — | — |
| Net income | -7.9M | -9.6M | -11M | -14M | -11M | -7.9M | -3.5M | -4M |
| Net margin | — | — | — | -2,842.2% | -2,234.6% | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
Tempest Therapeutics Earnings Trend Analysis
Over the eight quarters from Q1 '24 to Q4 '25, Tempest Therapeutics’s quarterly revenue moved from $0 to $0.
When Is Tempest Therapeutics’s Next Earnings Date?
Tempest Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q4 '25. For the confirmed upcoming date — and every other company reporting soon — see the TPST earnings calendar.
Frequently Asked Questions: Tempest Therapeutics Earnings
Tempest Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Tempest Therapeutics reported Q4 '25 revenue of $0, down 100.0% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the TPST AI Score.
